Literature DB >> 14768787

Tobacco industry efforts to keep cigarettes affordable: a case study from Hungary.

T Szilágyi1, S Chapman.   

Abstract

OBJECTIVE: To review strategies of multinational tobacco companies aimed at keeping tobacco products affordable to smokers in Hungary and to provide background information on the Hungarian request for the delayed introduction of minimum European Union tobacco excise duty levels.
METHOD: Review of internal tobacco industry documents available on the World Wide Web, downloaded between 26 July 2001 and 31 October 2002.
CONCLUSIONS: Appropriate pricing strategies and lobbying for low tobacco tax policies were used by the tobacco industry in Hungary to keep cigarettes affordable to the public. During the 1990s and in the early 2000s transnational tobacco companies (TTCs) were still able to prevent substantial cigarette price rises, which would have been desirable for more effective control of Hungarian tobacco use. Strategies used by TTCs included the creation of new partnerships, use of supportive MPs, communication around tobacco tax issues and also the successful management of the differences in approaches used by individual companies regarding taxation of tobacco products. These resulted in the adoption of governmental policy aimed at delaying the introduction of the EU directive on the minimum tax levels of retail prices of cigarettes.

Entities:  

Mesh:

Year:  2003        PMID: 14768787

Source DB:  PubMed          Journal:  Cent Eur J Public Health        ISSN: 1210-7778            Impact factor:   1.163


  15 in total

Review 1.  "A phony way to show sincerity, as we all well know": tobacco industry lobbying against tobacco control in Hong Kong.

Authors:  J Knight; S Chapman
Journal:  Tob Control       Date:  2004-12       Impact factor: 7.552

Review 2.  The vector of the tobacco epidemic: tobacco industry practices in low and middle-income countries.

Authors:  Sungkyu Lee; Pamela M Ling; Stanton A Glantz
Journal:  Cancer Causes Control       Date:  2012-02-28       Impact factor: 2.506

Review 3.  A review of the impacts of tobacco industry privatisation: Implications for policy.

Authors:  Anna B Gilmore; Gary Fooks; Martin McKee
Journal:  Glob Public Health       Date:  2011

4.  Transnational tobacco company influence on tax policy during privatization of a state monopoly: British American Tobacco and Uzbekistan.

Authors:  Anna Gilmore; Jeff Collin; Joy Townsend
Journal:  Am J Public Health       Date:  2006-11-30       Impact factor: 9.308

5.  "The lobbying strategy is to keep excise as low as possible" - tobacco industry excise taxation policy in Ukraine.

Authors:  Konstantin S Krasovsky
Journal:  Tob Induc Dis       Date:  2010-08-31       Impact factor: 2.600

Review 6.  What is known about tobacco industry efforts to influence tobacco tax? A systematic review of empirical studies.

Authors:  Katherine E Smith; Emily Savell; Anna B Gilmore
Journal:  Tob Control       Date:  2012-08-12       Impact factor: 7.552

Review 7.  Price and tax measures and illicit trade in the framework convention on tobacco control: what we know and what research is required.

Authors:  Corne van Walbeek; Evan Blecher; Anna Gilmore; Hana Ross
Journal:  Nicotine Tob Res       Date:  2012-09-17       Impact factor: 4.244

8.  Exposing and addressing tobacco industry conduct in low-income and middle-income countries.

Authors:  Anna B Gilmore; Gary Fooks; Jeffrey Drope; Stella Aguinaga Bialous; Rachel Rose Jackson
Journal:  Lancet       Date:  2015-03-14       Impact factor: 79.321

9.  Is income or employment a stronger predictor of smoking than education in economically less developed countries? A cross-sectional study in Hungary.

Authors:  Mall Leinsalu; Csilla Kaposvári; Anton E Kunst
Journal:  BMC Public Health       Date:  2011-02-13       Impact factor: 3.295

10.  Tobacco industry manipulation of tobacco excise and tobacco advertising policies in the Czech Republic: an analysis of tobacco industry documents.

Authors:  Risako Shirane; Katherine Smith; Hana Ross; Karin E Silver; Simon Williams; Anna Gilmore
Journal:  PLoS Med       Date:  2012-06-26       Impact factor: 11.069

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.